Please Wait.....
Report
Global Market for Contract Research Organization (CRO) Services
Market Research Report I 2024-10-11 I 169 Pages I BCC Research
Description
Report Scope
This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.
As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.
The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.
This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market's competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.
Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.
This report's goals include:
- Analyzing technologies and applications.
- Analyzing global market size and segmentation.
- Understanding market constraints and drivers.
- Providing detailed market forecasts through 2029.
- Assessing market shares, competitiveness and industry structure.
- Identifying potential long-term impacts on the CRO services market.
Report Includes
- 86 data tables and 33 additional tables
- An overview of the current and future global market for contract research organization (CRO) services
- Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region
- Information on CDISC standards, and regulations on sponsor activities; discussion of the impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
- Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.
Executive Summary
Summary:
Contract research organizations play a crucial role in the biotech, pharmaceutical and medical industries as they help their clients conduct clinical trials focused on the development of new medications and medical devices. CROs offer full drug development capabilities, enabling organizations to quickly and economically navigate regulatory and market access barriers. Ultimately, this helps reduce costs in specialized markets.
The global CRO market's value has surged due to increased outsourcing resulting from three main factors: specialized demand, patent expiration and the rise of generic drugs. Pharmaceutical companies are looking for ways to achieve cost savings and efficiency in clinical trials, which is causing increased time-to-market pressures and margin awareness. This integrated pharma-CRO partnership results in efficiency gains, making it ideal for clinical trials with high complexity, strict timelines or broad scope.
Presently, pharma pipelines are full with advanced treatments, including regenerative cell-based therapies, CAR-T, immune-oncology combinations and autoimmune therapies. Clinical trials that utilize advanced data and analytics to enhance adaptive trial designs and patient selection, and thereby ensure the development of cutting-edge treatments for market release, are underway worldwide. Adaptive design and risk-based monitoring in studies can reduce costs and allow for adjustments as research progresses. These methods improve drug discovery, patient safety and reduce risks for patients and pharmaceutical companies. As a result, patient receptivity is high, and this is leading to the rapid growth of clinical trials globally.
Increasing numbers of chronic diseases and rising drug discovery are also boosting the growth. Chronic disease affects hundreds of millions of patients globally. Approximately 45% of the population of the Americas, or 133 million people, suffer from one or more chronic health condition. Similarly, in Europe, nearly 60 million people have more than one chronic disease. The prevalence of chronic disease is expected to rise rapidly in the forecast period (2024-2029), and this is expected to create a significant burden on global healthcare.
This unprecedented release of drugs in the market by wealthy pharmaceutical companies, is benefitting CROs. These organizations are leveraging their experience in specific clinical research phases to capitalize on the increasing importance of cost-effectiveness and time-to-market acceleration in the competitive and time-sensitive drug development market.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Adoption of AI in CROs
R&D Investment in Biotech & Pharma Companies
Rising Prevalence of Chronic and Immunological Diseases Globally
CROs Add Efficiency
Market Restraints
Challenges in CRO Outsourcing
Shortage of Skilled Professionals
Market Opportunities
Inorganic Strategies
Chapter 4 Regulatory Landscape
FDA Regulation and Impact
Regulations on Sponsor Activities
CDISC Standards
BIMO Program
European Standards
Chapter 5 Emerging Technologies
Overview
Computer-Based Techniques
Decentralized Clinical Trials
Advanced Analytics and Simulation
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market CRO Services by Functional Services
Global Market Size and Forecast
Clinical Trials
Preclinical Research
Drug Discovery
Central Lab
Global Market for CRO Services by Therapeutic Area
Global Market Size and Forecast
Oncology
Cardiology
Metabolic
Neurology
Immunology
Other Applications
Global Market for CRO Services, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Academic Research Institutions
Geographic Breakdown
Global Market for CRO Services by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World
Chapter 7 Competitive Intelligence
Overview
Competitive Landscape
Mergers and Acquisitions
SWOT Analysis
Strengths of the Global Market for CRO Services
Weaknesses of the Global Market for CRO Services
Opportunities in the Global Market for CRO Services
Threats to the Global Market for CRO Services
Chapter 8 Sustainability in CRO Services Market: An ESG Perspective
Introduction to ESG
Sustainability in the CRO Services Market
ESG Perspective
Environmental Impact
Social Impact
Governance
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
CHARLES RIVER LABORATORIES
FRONTAGE LABS.
ICON PLC
IQVIA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDPACE
PAREXEL INTERNATIONAL CORP.
SYNEOS HEALTH
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
List of Tables
Summary Table : Global Market for CRO Services, by Functional Services, Through 2029
Table 1 : Summary of Porter's Five Forces Analysis: CRO Services Market
Table 2 : Global Market for CRO Services, by Functional Services, Through 2029
Table 3 : Clinical Trail Illustration
Table 4 : Clinical Trial Phase Description
Table 5 : Global Market for CRO Services in Clinical Trials, by Region, Through 2029
Table 6 : Global Market for CRO Services in Preclinical Research, by Region, Through 2029
Table 7 : Global Market for CRO Services in Drug Discovery, by Region, Through 2029
Table 8 : Global Market for CRO Services in Central Laboratories, by Region, Through 2029
Table 9 : Global Market for CRO Services, by Therapeutic Area, Through 2029
Table 10 : Global Market for CRO Services in Oncology, by Region, Through 2029
Table 11 : Global Market for CRO Services in Cardiology, by Region, Through 2029
Table 12 : Global Market for CRO Services in Metabolic Diseases, by Region, Through 2029
Table 13 : Global Market for CRO Services in Neurology, by Region, Through 2029
Table 14 : Global Market for CRO Services in Immunological Disorders, by Region, Through 2029
Table 15 : Global Market for CRO Services in Other Therapeutic Areas, by Region, Through 2029
Table 16 : Global Market for CRO Services, by End User, Through 2029
Table 17 : Global Market for CRO Services in Biopharmaceutical Companies, by Region, Through 2029
Table 18 : Global Market for CRO Services in Academic Research Institutions, by Region, Through 2029
Table 19 : Global Market for CRO Services, by Region, Through 2029
Table 20 : Diabetes Estimates in North America, by Country, 2000-2045
Table 21 : North American Market for CRO Services, by Functional Services, Through 2029
Table 22 : North American Market for CRO Services, by Therapeutic Area, Through 2029
Table 23 : North American Market for CRO Services, by End User, Through 2029
Table 24 : North American Market for CRO Services, by Country, Through 2029
Table 25 : U.S. Market for CRO Services, by Functional Services, Through 2029
Table 26 : U.S. Market for CRO Services, by Therapeutic Area, Through 2029
Table 27 : U.S. Market for CRO Services, by End User, Through 2029
Table 28 : Canadian Market for CRO Services, by Functional Services, Through 2029
Table 29 : Canadian Market for CRO Services, by Therapeutic Area, Through 2029
Table 30 : Canadian Market for CRO Services, by End User, Through 2029
Table 31 : Mexican Market for CRO Services, by Functional Services, Through 2029
Table 32 : Mexican Market for CRO Services, by Therapeutic Area, Through 2029
Table 33 : Mexican Market for CRO Services, by End User, Through 2029
Table 34 : Diabetes Estimates for the Top 10 European Countries, 2000-2045
Table 35 : European Market for CRO Services, by Functional Services, Through 2029
Table 36 : European Market for CRO Services, by Therapeutic Area, Through 2029
Table 37 : European Market for CRO Services, by End User, Through 2029
Table 38 : European Market for CRO Services, by Country, Through 2029
Table 39 : German Market for CRO Services, by Functional Services, Through 2029
Table 40 : German Market for CRO Services, by Therapeutic Area, Through 2029
Table 41 : German Market for CRO Services, by End User, Through 2029
Table 42 : U.K. Market for CRO Services, by Functional Services, Through 2029
Table 43 : U.K. Market for CRO Services, by Therapeutic Area, Through 2029
Table 44 : U.K. Market for CRO Services, by End User, Through 2029
Table 45 : French Market for CRO Services, by Functional Services, Through 2029
Table 46 : French Market for CRO Services, by Therapeutic Area, Through 2029
Table 47 : French Market for CRO Services, by End User, Through 2029
Table 48 : Rest of the European Market for CRO Services, by Functional Services, Through 2029
Table 49 : Rest of the European Market for CRO Services, by Therapeutic Area, Through 2029
Table 50 : Rest of the European Market for CRO Services, by End User, Through 2029
Table 51 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 52 : Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
Table 53 : Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
Table 54 : Asia-Pacific Market for CRO Services, by End User, Through 2029
Table 55 : Asia-Pacific Market for CRO Services, by Country, Through 2029
Table 56 : Chinese Market for CRO Services, by Functional Services, Through 2029
Table 57 : Chinese Market for CRO Services, by Therapeutic Area, Through 2029
Table 58 : Chinese Market for CRO Services, by End User, Through 2029
Table 59 : Japanese Market for CRO Services, by Functional Services, Through 2029
Table 60 : Japanese Market for CRO Services, by Therapeutic Area, Through 2029
Table 61 : Japanese Market for CRO Services, by End User, Through 2029
Table 62 : Indian Market for CRO Services, by Functional Services, Through 2029
Table 63 : Indian Market for CRO Services, by Therapeutic Area, Through 2029
Table 64 : Indian Market for CRO Services, by End User, Through 2029
Table 65 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
Table 66 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
Table 67 : Rest of Asia-Pacific Market for CRO Services, by End User, Through 2029
Table 68 : Rest of the World Market for CRO Services, by Functional Services, Through 2029
Table 69 : Rest of the World Market for CRO Services, by Therapeutic Area, Through 2029
Table 70 : Rest of the World Market for CRO Services, by End User, Through 2029
Table 71 : Rest of the World Market for CRO Services, by Sub-Region, Through 2029
Table 72 : South American Market for CRO Services, by Functional Services, Through 2029
Table 73 : South American Market for CRO Services, by Therapeutic Area, Through 2029
Table 74 : South American Market for CRO Services, by End User, Through 2029
Table 75 : Middle Eastern and African Market for CRO Services, by Functional Services, Through 2029
Table 76 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, Through 2029
Table 77 : Middle Eastern and African Market for CRO Services, by End User, Through 2029
Table 78 : Service Offerings, Major CROs
Table 79 : Pharmaceutical and CRO Partnership Alliances
Table 80 : Recent M&As in CROs Services Market, 2020-2024
Table 81 : Key ESG Metrics in the CRO Services Market
Table 82 : ESG Rankings for CRO Services
Table 83 : Abbreviations Used in this Report
Table 84 : Report Sources
Table 85 : Charles River Laboratories: Company Snapshot
Table 86 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 87 : Charles River Laboratories: Service Portfolio
Table 88 : Charles River Laboratories: News/Key Developments, 2021-2024
Table 89 : Frontage Labs.: Company Snapshot
Table 90 : Frontage Labs.: Financial Performance, FY 2022 and 2023
Table 91 : Frontage Labs.: Product Portfolio
Table 92 : Frontage Labs.: News/Key Development, 2022-2024
Table 93 : ICON plc: Company Snapshot
Table 94 : ICON plc: Financial Performance, FY 2022 and 2023
Table 95 : ICON plc: Product Portfolio
Table 96 : ICON plc: News/Key Development, 2020-2023
Table 97 : IQVIA Inc.: Company Snapshot
Table 98 : IQVIA Inc.: Financial Performance, FY 2022 and 2023
Table 99 : IQVIA Inc.: Service Portfolio
Table 100 : IQVIA Inc.: News/Key Developments, 2024
Table 101 : Laboratory Corporation of America Holdings: Company Snapshot
Table 102 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 103 : Laboratory Corporation of America Holdings: Service Portfolio
Table 104 : Laboratory Corporation of America Holdings: News/Key Developments, 2024
Table 105 : Medpace: Company Snapshot
Table 106 : Medpace: Financial Performance, FY 2022 and 2023
Table 107 : Medpace: Service Portfolio
Table 108 : Parexel International Corp.: Company Snapshot
Table 109 : Parexel International Corp.: Service Portfolio
Table 110 : Syneos Health: Company Snapshot
Table 111 : Syneos Health: Service Portfolio
Table 112 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 113 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 114 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 115 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
Table 116 : WuXi AppTec: Company Snapshot
Table 117 : WuXi AppTec: Financial Performance, FY 2022 and 2023
Table 118 : WuXi AppTec: Service Portfolio
List of Figures
Summary Figure : Global Market for CRO Services, by Functional Services, 2021-2029
Figure 1 : CRO Services: Market Dynamics
Figure 2 : Global Market Shares of CRO Services, by Functional Services, 2023
Figure 3 : Overall Phase Transition Success Rates in Biologic Drug Development
Figure 4 : Phase II Transition Success Rates, by Disease Area, 2021
Figure 5 : Phase III Transition Success Rates, by Disease Area, 2021
Figure 6 : Global Market Shares of CRO Services Throughout the Clinical Trial Process, by Phase, 2023
Figure 7 : Phase IV Transition Success Rates, by Disease Area, 2021
Figure 8 : Global Market for CRO Services in Clinical Trials, by Region, 2021-2029
Figure 9 : Global Market for CRO Services in Preclinical Research, by Region, 2021-2029
Figure 10 : CRO Services Related to Drug Discovery
Figure 11 : Global Market for CRO Services in Drug Discovery, by Region, 2021-2029
Figure 12 : Global Market for CRO Services in Central Laboratories, by Region, 2021-2029
Figure 13 : Global Market Shares of CRO Services, by Therapeutic Area, 2023
Figure 14 : Global Market Shares of CRO Services in Oncology, by Region, 2023
Figure 15 : Global Market Shares of CRO Services in Cardiology, by Region, 2023
Figure 16 : Global Market Shares of CRO Services in Metabolic Diseases, by Region, 2023
Figure 17 : Global Market Shares of CRO Services in Neurology, by Region, 2023
Figure 18 : Global Market Shares of CRO Services in Immunological Disorders, by Region, 2023
Figure 19 : Global Market Shares of CRO Services in Other Therapeutic Areas, by Region, 2023
Figure 20 : Global Market Shares of CRO Services, by End User, 2023
Figure 21 : Global Market Shares of CRO Services in Biopharmaceutical companies, by Region, 2023
Figure 22 : Global Market Shares of CRO Services in Academic Research Institutions, by Region, 2023
Figure 23 : Global Market for CRO Services, by Region, 2021-2029
Figure 24 : North American Market for CRO Services, by Functional Services, 2021-2029
Figure 25 : North American Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 26 : North American Market for CRO Services, by End User, 2021-2029
Figure 27 : North American Market Shares of CRO Services, by Country, 2023
Figure 28 : U.S. Market for CRO Services, by Functional Services, 2021-2029
Figure 29 : U.S. Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 30 : U.S. Market for CRO Services, by End User, 2021-2029
Figure 31 : Canadian Market for CRO Services, by Functional Services, 2021-2029
Figure 32 : Canadian Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 33 : Canadian Market for CRO Services, by End User, 2021-2029
Figure 34 : Mexican Market for CRO Services, by Functional Services, 2021-2029
Figure 35 : Mexican Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 36 : Mexican Market for CRO Services, by End User, 2021-2029
Figure 37 : European Market for CRO Services, by Functional Services, 2021-2029
Figure 38 : European Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 39 : European Market for CRO Services, by End User, 2021-2029
Figure 40 : European Market Shares of CRO Services, by Country, 2023
Figure 41 : German Market for CRO Services, by Functional Services, 2021-2029
Figure 42 : German Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 43 : German Market for CRO Services, by End User, 2021-2029
Figure 44 : U.K. Market for CRO Services, by Functional Services, 2021-2029
Figure 45 : U.K. Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 46 : U.K. Market for CRO Services, by End User, 2021-2029
Figure 47 : French Market for CRO Services, by Functional Services, 2021-2029
Figure 48 : French Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 49 : French Market for CRO Services, by End User, 2021-2029
Figure 50 : Rest of the European Market for CRO Services, by Functional Services, 2021-2029
Figure 51 : Rest of the European Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 52 : Rest of the European Market for CRO Services, by End User, 2021-2029
Figure 53 : Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
Figure 54 : Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 55 : Asia-Pacific Market for CRO Services, by End User, 2021-2029
Figure 56 : Asia-Pacific Market Shares of CRO Services, by Country, 2023
Figure 57 : Chinese Market for CRO Services, by Functional Services, 2021-2029
Figure 58 : Chinese Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 59 : Chinese Market for CRO Services, by End User, 2021-2029
Figure 60 : Japanese Market for CRO Services, by Functional Services, 2021-2029
Figure 61 : Japanese Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 62 : Japanese Market for CRO Services, by End User, 2021-2029
Figure 63 : Indian Market for CRO Services, by Functional Services, 2021-2029
Figure 64 : Indian Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 65 : Indian Market for CRO Services, by End User, 2021-2029
Figure 66 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
Figure 67 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 68 : Rest of Asia-Pacific Market for CRO Services, by End User, 2021-2029
Figure 69 : Rest of the World Market for CRO Services, by Functional Services, 2021-2029
Figure 70 : Rest of the World Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 71 : Rest of the World Market for CRO Services, by End User, 2021-2029
Figure 72 : Rest of the World Market Shares of CRO Services, by Sub-Region, 2023
Figure 73 : South American Market for CRO Services, by Functional Services, 2021-2029
Figure 74 : South American Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 75 : South American Market for CRO Services, by End User, 2021-2029
Figure 76 : Middle Eastern and African Market for CRO Services, by Functional Services, 2021-2029
Figure 77 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 78 : Middle Eastern and African Market for CRO Services, by End User, 2021-2029
Figure 79 : Global Market Shares of CRO Services, by Company, 2020
Figure 80 : SWOT Analysis of the CRO Services Market
Figure 81 : Pillars of ESG
Figure 82 : Advantages of ESG for CRO Services Companies
Figure 83 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 84 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 85 : Frontage Labs.: Revenue Share, by Business Unit, FY 2023
Figure 86 : Frontage Labs.: Revenue Share, by Country/Region, FY 2023
Figure 87 : ICON plc: Revenue Share, by Country/Region, FY 2023
Figure 88 : IQVIA Inc: Revenue Share, by Business Unit, FY 2023
Figure 89 : IQVIA Inc: Revenue Share, by Country/Region, FY 2023
Figure 90 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 91 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 92 : Medpace: Revenue Share, by Business Unit, FY 2023
Figure 93 : Medpace: Revenue Share, by Country/Region, FY 2023
Figure 94 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 95 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 96 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
Figure 97 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security